-
Something wrong with this record ?
Nurse-led sedation for transfemoral transcatheter aortic valve implantation seems safe for a selected patient population
V. Kočka, M. Nováčková, L. Kratochvílová, A. Širáková, J. Sulženko, T. Buděšínský, M. Bystroń, M. Neuberg, P. Mašek, F. Bednář, M. Stern, AP. Toušek
Language English Country Great Britain
Document type Journal Article
NLK
Free Medical Journals
from 1996 to 1 year ago
Open Access Digital Library
from 1996-01-01
- Publication type
- Journal Article MeSH
Transcatheter aortic valve implantation (TAVI) has become a high-volume procedure with increasing demands on hospital resources. Local anaesthesia with sedation supervised by an anaesthesiology team is the current standard of care. We aimed to describe our experience with a simplified, nurse-led sedation (NLS) protocol. This study enrolled 128 consecutive patients who underwent transfemoral TAVI with self-expandable Evolut R prosthesis between November 2019 and April 2021. Operators selected 50% of patients for NLS based on the clinical expectation of lower risk of procedural difficulties. Nurse-led sedation protocol demanded only mild to moderate levels of sedation. The clinical outcomes were determined from the local TAVI registry and the national mortality database. Baseline patient characteristics were similar in the NLS (n = 64) and anaesthesiologist-led sedation (ALS) (n = 64) groups except higher prevalence of diabetes mellitus (48.4% vs. 31.3%, P = 0.035) and peripheral vascular disease (20.3% vs. 7.8%, P = 0.036) in the ALS group. There was a trend for the larger prostheses used in the ALS group (P = 0.058). The procedural results did not differ, and coronary care team backup was rarely needed in the NLS group (6% of patients). The in-hospital outcomes were identical from both clinical and echocardiography perspectives, and 30-day mortality was low in both groups (1.5%). For the NLS group, preparation in the catheterization laboratory was quicker by 6.4 min (P = 0.01), and intensive care unit stay was shorter (2.03 vs. 3.48 days, P = 0.001). In conclusion, the NLS for the selected transfemoral TAVI population seems safe.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22017488
- 003
- CZ-PrNML
- 005
- 20220720100241.0
- 007
- ta
- 008
- 220718s2022 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/eurheartjsupp/suac004 $2 doi
- 035 __
- $a (PubMed)35370506
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Kočka, Viktor $u Department of Cardiology, Third Faculty of Medicine, University Hospital Královské Vinohrady, Charles University, Šrobárova 50, Prague 100 34, Czech Republic
- 245 10
- $a Nurse-led sedation for transfemoral transcatheter aortic valve implantation seems safe for a selected patient population / $c V. Kočka, M. Nováčková, L. Kratochvílová, A. Širáková, J. Sulženko, T. Buděšínský, M. Bystroń, M. Neuberg, P. Mašek, F. Bednář, M. Stern, AP. Toušek
- 520 9_
- $a Transcatheter aortic valve implantation (TAVI) has become a high-volume procedure with increasing demands on hospital resources. Local anaesthesia with sedation supervised by an anaesthesiology team is the current standard of care. We aimed to describe our experience with a simplified, nurse-led sedation (NLS) protocol. This study enrolled 128 consecutive patients who underwent transfemoral TAVI with self-expandable Evolut R prosthesis between November 2019 and April 2021. Operators selected 50% of patients for NLS based on the clinical expectation of lower risk of procedural difficulties. Nurse-led sedation protocol demanded only mild to moderate levels of sedation. The clinical outcomes were determined from the local TAVI registry and the national mortality database. Baseline patient characteristics were similar in the NLS (n = 64) and anaesthesiologist-led sedation (ALS) (n = 64) groups except higher prevalence of diabetes mellitus (48.4% vs. 31.3%, P = 0.035) and peripheral vascular disease (20.3% vs. 7.8%, P = 0.036) in the ALS group. There was a trend for the larger prostheses used in the ALS group (P = 0.058). The procedural results did not differ, and coronary care team backup was rarely needed in the NLS group (6% of patients). The in-hospital outcomes were identical from both clinical and echocardiography perspectives, and 30-day mortality was low in both groups (1.5%). For the NLS group, preparation in the catheterization laboratory was quicker by 6.4 min (P = 0.01), and intensive care unit stay was shorter (2.03 vs. 3.48 days, P = 0.001). In conclusion, the NLS for the selected transfemoral TAVI population seems safe.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Nováčková, Markéta $u Department of Cardiology, Third Faculty of Medicine, University Hospital Královské Vinohrady, Charles University, Šrobárova 50, Prague 100 34, Czech Republic
- 700 1_
- $a Kratochvílová, Lenka $u Medtronic Czechia, Prosecká 66, Prague 190 00, Czech Republic
- 700 1_
- $a Širáková, Andrea $u Department of Cardiology, Third Faculty of Medicine, University Hospital Královské Vinohrady, Charles University, Šrobárova 50, Prague 100 34, Czech Republic
- 700 1_
- $a Sulženko, Jakub $u Department of Cardiology, Third Faculty of Medicine, University Hospital Královské Vinohrady, Charles University, Šrobárova 50, Prague 100 34, Czech Republic
- 700 1_
- $a Buděšínský, Tomáš $u Department of Cardiology, Third Faculty of Medicine, University Hospital Královské Vinohrady, Charles University, Šrobárova 50, Prague 100 34, Czech Republic
- 700 1_
- $a Bystroń, Marian $u Department of Cardiology, Third Faculty of Medicine, University Hospital Královské Vinohrady, Charles University, Šrobárova 50, Prague 100 34, Czech Republic
- 700 1_
- $a Neuberg, Marek $u Medtronic Czechia, Prosecká 66, Prague 190 00, Czech Republic
- 700 1_
- $a Mašek, Petr $u Medtronic Czechia, Prosecká 66, Prague 190 00, Czech Republic
- 700 1_
- $a Bednář, František $u Department of Cardiology, Third Faculty of Medicine, University Hospital Královské Vinohrady, Charles University, Šrobárova 50, Prague 100 34, Czech Republic
- 700 1_
- $a Stern, Michael $u Department of Anaesthesia and Intensive Care Medicine, Third Faculty of Medicine, University Hospital Královské Vinohrady, Charles University, Šrobárova 50, Prague 100 34, Czech Republic
- 700 1_
- $a Toušek, And Petr $u Department of Cardiology, Third Faculty of Medicine, University Hospital Královské Vinohrady, Charles University, Šrobárova 50, Prague 100 34, Czech Republic
- 773 0_
- $w MED00005247 $t European heart journal supplements : journal of the European Society of Cardiology $x 1520-765X $g Roč. 24, Suppl B (2022), s. B23-B27
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35370506 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220718 $b ABA008
- 991 __
- $a 20220720100236 $b ABA008
- 999 __
- $a ind $b bmc $g 1816611 $s 1168730
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 24 $c Suppl B $d B23-B27 $e 20220330 $i 1520-765X $m European heart journal supplements $n Eur Heart J Suppl $x MED00005247
- LZP __
- $a Pubmed-20220718